While anti-VEGF therapies remain the current standard of care, many DME patients experience suboptimal responses due to ...

GLP-1 receptor agonists and fenofibrate medications significantly reduced the risk for developing diabetic macular edema, ...

Continuous Glucose Monitoring (CGM) is transforming diabetes care—and creating one of the most promising growth opportunities ...

Ashvin AI, a startup based here that calls itself “the financial operating system for DME providers,” emerged from stealth mode at the HME News Business Summit on Oct. 20 in Cleveland.

EyePoint faces clinical, commercial hurdles despite DME, AMD progress and solid funding through 2027. Read why EYPT stock is ...

EyePoint Pharmaceuticals outlines Phase 3 trials for Duravyu in diabetic macular edema, backed by $150 million in new funding ...

Aeroflow Sleep, a national durable medical equipment (DME) provider specializing in CPAP supplies, today announced the results of a proprietary survey highlighting a significant disconnect in sleep ...

Based on data including more than 788 million patient visits from more than 15,000 ophthalmologists, thousands of eyes were ...

One Health Direct (OHD) announced today that its internal operational platform, runOMNI, will soon be available as a standalone SaaS offering for other DME suppliers that want to modernize and scale ...

Aeroflow Sleep, a national durable medical equipment (DME) provider specializing in CPAP supplies, today announced the results of a proprietary survey highlighting ...